Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Lamb

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Ecological Applications : a Publication of the Ecological Society of America|April 17, 2024
Effectiveness of population-based recovery actions for threatened southern mountain caribouClayton T Lamb, Sara Williams, Stan Boutin, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Brain : a Journal of Neurology|January 24, 2018
Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse modelChad A Tagge, Andrew M Fisher, Olga V Minaeva, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PETKwangsik Nho, Shannon L Risacher, Liana Apostolova, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Frontiers in Aging Neuroscience|July 11, 2022
<i>Plcg2</i> Interacts With High Fat/High Sugar Diet to Accelerate Alzheimer's Disease-Relevant Phenotypes in MiceAdrian L Oblak, Kevin P Kotredes, Ravi S Pandey, et al.
Alzheimer'S & Dementia (New York, N. Y.)|August 26, 2022
Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core studyKristen D Onos, Sara K Quinney, David R Jones, et al.
Frontiers in Aging Neuroscience|August 9, 2021
Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD StudyAdrian L Oblak, Peter B Lin, Kevin P Kotredes, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 18, 2022
Prophylactic evaluation of verubecestat on disease- and symptom-modifying effects in 5XFAD miceAdrian L Oblak, Zackary A Cope, Sara K Quinney, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Ecological Applications : a Publication of the Ecological Society of America|April 17, 2024
Effectiveness of population-based recovery actions for threatened southern mountain caribouClayton T Lamb, Sara Williams, Stan Boutin, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Brain : a Journal of Neurology|January 24, 2018
Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse modelChad A Tagge, Andrew M Fisher, Olga V Minaeva, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Novel <i>CYP1B1-RMDN2</i> Alzheimer's disease locus identified by genome-wide association analysis of cerebral tau deposition on PETKwangsik Nho, Shannon L Risacher, Liana Apostolova, et al.
Pageof 26